Patients should understand that expected weight loss varies by medication (approximately 5-10% with liraglutide, 10-15% with semaglutide, and potentially higher with tirzepatide), though responses in post-bariatric patients may differ from those in primary obesity treatment
Not only can getting enough protein help support GLP-1, but it can contribute to weight loss support in a variety of other ways
PMID: 37967718 Aquaculture2025 Oct 27
Limited Long-Term Research There is still limited long-term data on the safety of AOD-9604, especially with extended use
Fatigue or headaches may linger for several days to weeks, depending on how sensitive you are to the medication
If you have any specific questions or concerns about your health, please talk to your primary care provider (PCP)